Sandoz Around the World
Navigate within 'Sandoz Around the World'
Sandoz launches generic Lipitor® across EU countries
Holzkirchen, Germany, May 14, 2012
Sandoz has launched atorvastatin film-coated tablets across countries of the European Union (EU), including in Belgium, Denmark, France, Germany (through its affiliate 1A Pharma GmbH), Ireland, Italy, the Netherlands and the United Kingdom, upon expiry of respective supplementary protection certificates (SPCs).
Community Partnership Day
April 26, 2012
1800 Sandoz associates join a Novartis global team of more than 25,000 to volunteer for local causes in Community Partnership Day.
Sandoz completes US offering of generic Lovenox® line with launch of enoxaparin sodium injection, USP vials
Princeton, New Jersey, April 25, 2012
Sandoz today announced the introduction of enoxaparin
sodium injection, USP 3 mL vials, a generic version of Sanofi’s Lovenox® Injection Multiple-Dose Vials, in
the US.
Sandoz enters local Cameroon production partnership to increase access to quality medicines in Sub-Saharan Africa
Yaoundé, Cameroon, April 23, 2012
Sandoz is pleased to announce that its German affiliate, 1A Pharma GmbH (1A Pharma), has signed an important partnership agreement with Cinpharm S.A. (Cinpharm), a Cameroon-owned and operated generic pharmaceuticals manufacturing company for the production of high-quality medicines for the Sub-Saharan African region.
First Barmer GEK Tender Awarded
Holzkirchen, March 07, 2012
Sandoz group clearly ahead with over a third of contracts won.
Atorvastatin HEXAL®: Significant relief before patent expiration
Holzkirchen, March 06, 2012
Nine weeks before the expiration of the patent, HEXAL is launching Atorvastatin HEXAL® into the market.
Sandoz introduces authorized generic version of Clobex® Shampoo, 0.05%
Princeton, New Jersey, January 03, 2012
Sandoz today announced the introduction of clobetasol
propionate shampoo, 0.05%, an authorized generic version of Clobex® Shampoo, 0.05%, in the US.
Sandoz launches voriconazole tablets, a generic version of Vfend®
Princeton, New Jersey, December 20, 2011
Sandoz today announced the US Food and Drug
Administration (FDA) approval and US launch of voriconazole tablets, a generic equivalent of Vfend®.
Lek among the top 10
Ljubljana, November 25, 2011
Systematic investments in employee education and training
Lek among the most reputable employers in Slovenia
Ljubljana, November 24, 2011
As a part of the annual career fair Moje Delo 2011, the awards for the most reputable Slovenian companies, a survey conducted by the recruitment portal MojeDelo.com (MyJob.com), named Lek, a Sandoz company, one of the most reputable employers in Slovenia.
